State NY
Clinical Trials in New York
Recruiting clinical trials with at least one study location in New York. Data updated daily from ClinicalTrials.gov.
Top Conditions in New York
NCT07158242 Phase 3
Recruiting
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7...
Condition
Moderately to Severely Active Ulcerative Colitis
Enrollment
100 pts
Location
United States, Taiwan, United Kingdom
Sponsor
Hoffmann-La Roche
NCT04696575 Phase 2
Recruiting
Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive...
Condition
Extensive Stage Lung Small Cell Carcinoma
Enrollment
28 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT05323253 N/A
Recruiting
A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Trea...
Condition
Recurrent Squamous Cell Carcinoma
Enrollment
86 pts
Location
United States, Canada, Israel
Sponsor
Alpha Tau Medical LTD.
NCT06773195 Phase 1, Phase 2
Recruiting
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibro...
Condition
Myelofibrosis
Enrollment
37 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05671757 Phase 1, Phase 2
Recruiting
Daratumumab in Primary Antiphospholipid Syndrome
Condition
Autoimmune Disorders
Enrollment
22 pts
Location
United States
Sponsor
National Institute of Allergy
NCT04991467 N/A
Recruiting
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
Condition
Parenting
Enrollment
360 pts
Location
United States
Sponsor
Albert Einstein College of Med
NCT05785754 Phase 1
Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastat...
Condition
Advanced or Metastatic Solid Tumors
Enrollment
320 pts
Location
United States, Australia, South Korea
Sponsor
DynamiCure Biotechnology
NCT06158841 Phase 3
Recruiting
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standa...
Condition
Multiple Myeloma
Enrollment
380 pts
Location
United States, Australia, Austria
Sponsor
AbbVie
NCT06486922 N/A
Recruiting
Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Intervention Deve...
Condition
Child Obesity
Enrollment
40 pts
Location
United States
Sponsor
Northwell Health
NCT06529575 N/A
Recruiting
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Ch...
Condition
Pediatric ALL
Enrollment
650 pts
Location
United States
Sponsor
University of Pennsylvania
NCT06908356 Phase 2
Recruiting
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults Wi...
Condition
Focal Onset Seizure
Enrollment
50 pts
Location
United States, Australia, Spain
Sponsor
Praxis Precision Medicines
NCT07039175 Phase 3
Recruiting
Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans Wit...
Condition
Tobacco Smoking
Enrollment
270 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07222722 N/A
Recruiting
NIRS Monitoring in the NICU and AKI
Condition
Acute Kidney Injury (AKI)
Enrollment
100 pts
Location
United States
Sponsor
NYU Langone Health
NCT05977751 N/A
Recruiting
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Condition
Contraception
Enrollment
573 pts
Location
United States
Sponsor
Femasys Inc.
NCT02074839 Phase 1
Recruiting
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malign...
Condition
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Enrollment
291 pts
Location
United States, France
Sponsor
Institut de Recherches Interna
NCT06543446 N/A
Recruiting
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
Condition
Heart Failure With Reduced Ejection Fraction
Enrollment
3,290 pts
Location
United States, Canada
Sponsor
University of Rochester
NCT05467930 N/A
Recruiting
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinic...
Condition
COVID-19
Enrollment
1,000 pts
Location
United States
Sponsor
Columbia University
NCT06343402 Phase 1
Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung...
Condition
Non-small Cell Lung Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
TheRas, Inc., d/b/a BBOT (Brid
NCT06465745 N/A
Recruiting
AltaValve Pivotal Trial
Condition
Mitral Regurgitation
Enrollment
450 pts
Location
United States, Germany, Greece
Sponsor
4C Medical Technologies, Inc.
NCT05605899 Phase 3
Recruiting
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-...
Condition
High-risk Large B-cell Lymphoma (LBCL)
Enrollment
300 pts
Location
United States, Australia, Austria
Sponsor
Kite, A Gilead Company
NCT05544019 Phase 1
Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
Condition
Mature B-Cell Neoplasm
Enrollment
98 pts
Location
United States, France, Italy
Sponsor
Schrödinger, Inc.
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States
Sponsor
NRG Oncology
NCT03911700 N/A
Recruiting
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Condition
Open Midline Laparotomy
Enrollment
477 pts
Location
United States, Austria, Belgium
Sponsor
C. R. Bard
NCT07107139 N/A
Recruiting
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Labor...
Condition
Smokeless Tobacco
Enrollment
50 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT06388564 Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ru...
Condition
Chronic Graft-versus-host-disease
Enrollment
120 pts
Location
United States, Belgium, Canada
Sponsor
Incyte Corporation